LivaNova PLC, Abbott and Medtronic – Notable Market Participants in Percutaneous Mechanical Circulatory Support Devices Market
The percutaneous mechanical circulatory support devices market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the percutaneous mechanical circulatory support devices market are present globally and have wide distribution and sales network through partnerships or authorized dealers.
The most notable percutaneous mechanical circulatory support devices market participants are Abbott, Medtronic, Getinge AB, Teleflex Incorporated, LivaNova PLC, ABIOMED, EUROSETS, Berlin Heart, Jarvik Heart, Inc., and CardioBridge GmbH
Market leaders are involved in extensive percutaneous mechanical circulatory support devices market research for the development of new products with advanced technology. For instance, in October 2018, Abbott received approval for the HeartMate 3 Left Ventricular Assist Device (LVAD) as a destination therapy for people living with advanced heart failure. With the approval, physicians can now offer the HeartMate 3 system to patients not eligible for a transplant who will live with their device for the rest of their lives. Subsequently, introduction of such advanced are expected to provide this market with lucrative growth opportunities.
| Year | News | Region |
| 2017 | Abbott completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The company is likely to be benefitted with the acquisition in terms of product portfolio diversification, and develop a strong pipeline of cardiovascular and neuromodulator patient care. | North America |
| 2016 | Medtronic completed acquisition of HeartWare International, Inc., a leading innovator of less-invasive, miniaturized, mechanical circulatory support technologies (MCS) for treating patients with advanced heart failure. HeartWare will become part of the Heart Failure business within the Medtronic Cardiac Rhythm and Heart Failure division. | North America |
| 2017 | Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, announced today the completion of its previously announced acquisition of Vascular Solutions, Inc. The combination is expected to meaningfully accelerate the growth of Teleflex’s vascular and interventional businesses by its entry into the coronary and peripheral vascular market, as well as increased cross-portfolio selling opportunities to both Teleflex and Vascular Solutions customer bases. | North America |
| 2018 | LivaNova PLC a market-leading medical technology company, closed its acquisition of TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions. The acquisition of TandemLife allows us to complement our portfolio with a complete set of solutions for Extracorporeal Life Support and Percutaneous Mechanical Circulatory Support | Europe |
